Blog list

Myopia is more than blurry distance vision - it’s a condition that can continue to worsen throughout childhood if left unmanaged. With myopia on the rise worldwide, early intervention is more important than ever. Modern myopia management offers proven solutions that go beyond traditional glasses to help slow progression and protect long-term eye health.

Myopia is becoming increasingly common in children, and managing it early is essential for protecting long-term eye health. Today, families have access to several clinically proven myopia control options, including Orthokeratology, MiSight contact lenses, and Essilor Stellest lenses. Each approach works differently, and understanding those differences can help parents choose the best solution for their child.

Orthokeratology, or Ortho-K, is an innovative treatment that uses specially designed contact lenses to gently reshape your cornea overnight. When worn as prescribed, Ortho-K lenses provide clear vision during the day without the need for glasses or daytime contacts.

On September 25, 2025, the FDA officially approved the Essilor Stellest™ lenses for children ages 6 to 12, marking a major milestone in myopia management in the United States. While these lenses have been widely used internationally since 2020 in Europe, Canada, and parts of Asia - this long-awaited approval now brings an advanced, non-invasive solution to families across the U.S.

Myopia, or nearsightedness, has become increasingly common among children and young adults. With more time spent on screens and less time outdoors, cases of progressive myopia continue to rise. Left unmanaged, worsening myopia not only makes daily activities more challenging but also increases the risk of serious eye conditions later in life, such as retinal detachment, glaucoma, and macular degeneration. One effective way to help manage and slow down myopia progression is through Orthokeratology (Ortho-K) lenses.